Hello,
I understand that enzalutmide and abiraterone tend to be an either / or proposition, despite there being some evidence that about 28% of men will respond to the second drug once the first has failed.
That said, I note that some members here do appear to have received both. I guess this could be down to different rules in England, Scotland, Ireland, Wales. It could also be down to flexibility on the part of the oncologists.
Has anybody received both and if so could you please elaborate re the circumstances?
Thanks
Jonathan.